Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Database access restrictions

Database licenses

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 7 result(s)
Reactome is a manually curated, peer-reviewed pathway database, annotated by expert biologists and cross-referenced to bioinformatics databases. Its aim is to share information in the visual representations of biological pathways in a computationally accessible format. Pathway annotations are authored by expert biologists, in collaboration with Reactome editorial staff and cross-referenced to many bioinformatics databases. These include NCBI Gene, Ensembl and UniProt databases, the UCSC and HapMap Genome Browsers, the KEGG Compound and ChEBI small molecule databases, PubMed, and Gene Ontology.
EUMETSAT's primary objective is to establish, maintain and exploit European systems of operational meteorological satellites. EUMETSAT is responsible for the launch and operation of the satellites and for delivering satellite data to end-users as well as contributing to the operational monitoring of climate and the detection of global climate changes. The EUMETSAT Product Navigator is the catalogue for all EUMETSAT data and products.
The CERN Open Data portal is the access point to a growing range of data produced through the research performed at CERN. It disseminates the preserved output from various research activities, including accompanying software and documentation which is needed to understand and analyze the data being shared.
The ODIN Portal hosts scientific databases in the domains of structural materials and hydrogen research and is operated on behalf of the European energy research community by the Joint Research Centre, the European Commission's in-house science service providing independent scientific advice and support to policies of the European Union. ODIN contains engineering databases (Mat-Database, Hiad-Database, Nesshy-Database, HTR-Fuel-Database, HTR-Graphit-Database) and document management sites and other information related to European research in the area of nuclear and conventional energy.
The European VLBI Network (EVN) is an interferometric array of radio telescopes located primarily in Europe and Asia, with additional telescopes in South Africa and Puerto Rico. The EVN performs high-resolution observations of cosmic radio sources at wavelenghts from 92cm to 7mm. The EVN Data Archive contains, among other things, the correlated data from EVN observations plus pipeline output, including the initial calibration tables to apply to the correlated data and preliminary images. In general, the correlated data and some pipeline results are proprietary for one year following distribution to the PI of the final epoch of observations resulting from a proposal after which the data enters the public domain; more details are in the "EVN Data Access Policy" linked via the archive-introduction page.
ChEMBL is a database of bioactive drug-like small molecules, it contains 2-D structures, calculated properties (e.g. logP, Molecular Weight, Lipinski Parameters, etc.) and abstracted bioactivities (e.g. binding constants, pharmacology and ADMET data). The data is abstracted and curated from the primary scientific literature, and cover a significant fraction of the SAR and discovery of modern drugs We attempt to normalise the bioactivities into a uniform set of end-points and units where possible, and also to tag the links between a molecular target and a published assay with a set of varying confidence levels. Additional data on clinical progress of compounds is being integrated into ChEMBL at the current time.